Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jinqiancao Capsules (金錢草膠囊) is an approved traditional Chinese medicine (TCM) product manufactured by Fung Wah (via its Gulin Tang Pharmaceutical Factory). The active ingredient is derived from *Lysimachia christinae* Hance (Christina's Loosestrife, also known as 'Gold Coin Grass'), a dried whole herb from the family Primulaceae. Jinqiancao is traditionally used in Chinese medicine for its therapeutic effects on hepatobiliary and urinary conditions, including gallstones, cholecystitis, and kidney stones. It exerts multi-component, multi-target pharmacological effects to clear damp-heat, induce diuresis, and promote the excretion of stones.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on jinqiancao capsules.